Have a feature idea you'd love to see implemented?
Let us know!
INAB In8Bio Inc
Price (delayed)
$0.32
Market cap
$23.19M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.75
Enterprise value
$24.67M
Highlights
The EPS has increased by 32% YoY and by 10% QoQ
In8Bio's debt has decreased by 7% from the previous quarter but it has increased by 4% YoY
In8Bio's quick ratio has plunged by 60% YoY and by 49% from the previous quarter
In8Bio's equity has plunged by 52% YoY and by 37% from the previous quarter
Key stats
What are the main financial stats of INAB
Market
Valuations
Earnings
Shares outstanding
72.48M
Market cap
$23.19M
Enterprise value
$24.67M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.74
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$31.88M
EBITDA
-$29.3M
Free cash flow
-$25.2M
Per share
Balance sheet
Liquidity
EPS
-$0.75
Free cash flow per share
-$0.53
Book value per share
$0.18
Revenue per share
$0
TBVPS
$0.34
Total assets
$15.97M
Total liabilities
$7.38M
Debt
$5.47M
Equity
$8.59M
Working capital
$3.07M
Debt to equity
0.64
Current ratio
1.84
Quick ratio
1.1
Net debt/EBITDA
-0.05
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-130.5%
Return on equity
-197.1%
Return on invested capital
-238.1%
Return on capital employed
-258.5%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
INAB stock price
How has the In8Bio stock price performed over time
Intraday
-0.47%
1 week
-4.76%
1 month
-32.63%
1 year
-56.46%
YTD
-76.81%
QTD
18.52%
Financial performance
How have In8Bio's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$32.04M
Net income
-$31.88M
Gross margin
N/A
Net margin
N/A
INAB's operating income is down by 6% year-on-year
INAB's net income is down by 6% YoY
Growth
What is In8Bio's growth rate over time
Valuation
What is In8Bio stock price valuation
P/E
N/A
P/B
1.74
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has increased by 32% YoY and by 10% QoQ
In8Bio's equity has plunged by 52% YoY and by 37% from the previous quarter
INAB's P/B is 21% below its last 4 quarters average of 2.2
Efficiency
How efficient is In8Bio business performance
The return on equity has declined by 29% year-on-year and by 14% since the previous quarter
The ROA has decreased by 23% YoY and by 10% from the previous quarter
In8Bio's ROIC has decreased by 16% YoY
Dividends
What is INAB's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for INAB.
Financial health
How did In8Bio financials performed over time
The total assets is 116% greater than the total liabilities
In8Bio's quick ratio has plunged by 60% YoY and by 49% from the previous quarter
The company's current ratio fell by 48% YoY and by 31% QoQ
In8Bio's debt is 36% less than its equity
In8Bio's debt to equity has surged by 113% YoY and by 49% QoQ
In8Bio's equity has plunged by 52% YoY and by 37% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.